China Investment Development

China Investment Development Limited is a Hong Kong-based investment holding company that specializes in identifying and funding high-growth opportunities within the life sciences, biotechnology, and healthcare sectors. Operating under Chapter 21 of the Hong Kong Stock Exchange listing rules, the company maintains a diversified portfolio of both listed and unlisted entities. Its strategic focus includes innovative medical technologies, skincare biotechnology, recombinant collagen products, and healthcare services, primarily within the Greater China region. The firm aims to achieve medium-to-long-term capital appreciation for its shareholders through proactive venture capital and private equity investments. In addition to its core healthcare focus, the company occasionally invests in environmental protection and logistics to maintain a balanced portfolio.